Investor Relations Overview

Corporate Profile

Greatbatch, Inc. (NYSE:GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance. The company designs, develops and manufactures critical medical device technologies for the cardiac, neuromodulation, vascular and orthopaedic markets, and power management solutions for high-end niche applications in the portable medical, energy, environmental and military markets.
NYSE | GB (common stock)
$36.58 - 0.39
Stock chart for: GB.  Currently trading at $36.58 with a 52 week high of $63.19 and a 52 week low of $35.77.
02/05/16 4:02 p.m. ET
Data Provided by Thomson Reuters

Press Releases more

Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS)

Read More

Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX Corporation

Read More

Greatbatch, Inc. Provides Preliminary 2015 Revenue Results and 2016 Guidance

Read More

Greatbatch Receives FDA Approval of Algovita(R) Spinal Cord Stimulation System

Read More

Recent SEC Filings more

Filing DateFormDescriptionDownloads
01/26/16SC 13G/AAn amendment to the SC 13G filing Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
01/25/164/AAmendment to a previously filed 4 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
01/25/164/AAmendment to a previously filed 4 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
01/19/164Statement of changes in beneficial ownership of securities Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable

Upcoming Events more